Now that she has joined Merck, new doors are opening in the local medical community. “Boston is really a powerhouse of oncology research,” said Dr. Richon, “and Merck has chosen this site here in the middle of that community, and is really promoting the kind of collaboration and interaction with clinicians and researchers that we need to develop our cancer research program. I can walk out the door and share ideas with colleagues in the Longwood medical area, or just go across the river to visit any of the great institutions in Cambridge. In fact, our network of collaborations extends around the world, all the way to the Peter MacCallum Cancer Center in Melbourne, Australia.”
By partnering with biotechnology and with the best academic research institutions and oncology clinics, MRL Boston is expediting the fight against cancer—the second leading cause of death in the U.S and much of the world.
[back ] 1 | 2
|
really promoting the kind of collaboration and interaction with clinicians and researchers that we need to develop our cancer research program. I can walk out the door and share ideas with colleagues in the Longwood medical area, or just go across the river to visit any of the great institutions in Cambridge. In fact, our network of collaborations extends around the world, all the way to the Peter MacCallum Cancer Center in Melbourne, Australia.”
Printer Friendly Page